Canada marijuana takes big step with federal report now complete Pharma executive behind OxyContin sells medical marijuana “3 Grams A Day” Canada Tells Veterans Who Use Marijuana Canopy Growth becomes Canada’s first marijuana unicorn, worth $1 billion Canadian Health Insurance Co. Says Yes to Covering Cannabis Costs Canada’s marijuana legalization plan flouts 3 UN drug conventions Will Canada become America’s cannabis capital? Canadian marijuana producer expands abroad Loblaw looks to get in on medical marijuana business Veterans Affairs must better manage drug plan, marijuana costs Let people smoke pot outside, says Colorado legislator Vancouver medical marijuana businesses must close by Friday if breaking rules Canadian Marijuana Companies Make Millions — But They Can’t Get a Bank Account Race to Develop Marijuana Breathalyzers Before Canada Legalizes Drug Canada is planning to decriminalize marijuana by 2017 U.S. experts urge Canada to cultivate social standards around marijuana Canada’s first national marijuana advertisement Canadian Pharmacists Association Eyes Medical Marijuana Canada’s Weed Policy Shows Way Forward On Blockchain Regulations Demand for Canada medical marijuana growing Four Canadians plead guilty to smuggling weed in Barbados Marijuana Helps Arthritis Using Medical Marijuana for Fibromyalgia Omission of marijuana reform in budget not a stall tactic – Ottawa Alberta liquor stores contemplating marijuana sales Canada Marijuana Infused Nutella – Chrontella Now Available Canadian Cannabis Producer Supreme Pharma Prepares to Enter Market Canadian official causes stir with ‘progressive’ speech at UN narcotics conference Teen marijuana use in Canada in decade decline Veterans’ marijuana prescriptions rise tenfold in 2 years, Ottawa asks questions Marijuana Drug Found to Reduce Epileptic Seizures Marijuana industry busily working to shed troubled past and go legal Legal history of marijuana in Canada Marapharm Ventures Acquires Growing Marijuana Business in Washington State Vancouver’s marijuana shops look toward Toronto Over 22,000 Marijuana Arrests Under Trudeau So Far Ontario government frowns on vaping and medical marijuana in public Squamish Council considers marijuana rules Health Canada awards company a hemp license Marijuana legalization in Canada is coming – Someday Legalize marijuana possession NOW! Legalizing marijuana: Health Canada flags 9 factors for Liberals to consider Canadian marijuana firms say illegal rivals costing them money Majority of Canadians agree pot should be legal Renowned chef stopped at Canadian border with over 20 pounds of marijuana edibles Shoppers Drug Mart eyes sales of Medical Marijuana Canadians Can Grow Their Own Medical Marijuana, Court Rules Halifax councilor takes on neighbor’s medical marijuana fight Princess Margaret pulls prize home from lottery – marijuana grow-op License appeals begin for Vancouver marijuana dispensaries Canada’s police chiefs want feds to remind people marijuana isn’t legal yet More palliative care patients should get medical marijuana: doctors Unlicensed medical marijuana sellers must still pay tax, appeal court rules Licensed pot shops coming to Vancouver as early as March Police seize $378K worth of marijuana plants from Winnipeg home Quebec backtracks on refusal to help legalize marijuana

Pharma executive behind OxyContin sells medical marijuana

medical marijuana

medical marijuana

John Stewart used to run the pharmaceutical company behind the narcotic painkiller OxyContin. Now he is banking on medical marijuana.

Mr Stewart does not know which is more controversial these days, OxyContin or pot.

He guesses the average person would give “a bigger negative” to the powerful and controversial painkiller that has been linked to the opioid overdose and addiction epidemic in the US and Canada.

“There is a lot of anti-opioid sentiment,” he says, delicately. “And certainly based on the social disruption that we’ve seen it’s understandable.”

In the US, an estimated 1.9 million Americans were addicted to prescription opioid painkillers in 2014. Accidental overdoses from prescription painkillers quadrupled between 1999 and 2012. In 2014, drug overdoses were the leading accidental cause of death south of the border, driven by prescription opioids.

North of the border, some 15% of Canadians have an opioid painkiller prescription and 2% of those report abusing the drug.

But Mr Stewart has turned his attention elsewhere. He left Purdue Pharma in 2013 and is now a co-founder of Emblem, a medical marijuana company based in Paris, Ontario.

He credits his time at Purdue Pharma, which did some early research into therapeutic cannabis but never brought a drug to market, for sparking his current interest – finding better ways to deliver the medical benefits of cannabis to patients.

Marketplace newcomer

Now, his new job might just end up eating away at the bottom line of opioid manufacturers like the one he once worked for.

Doctors prescribe less pain medication in medical marijuana states. Recent research out of the University of British Columbia suggests cannabis has potential in helping to ease alcoholics and people addicted to opioids off their habit.

But Mr Stewart maintains there is still a place for powerful opioids that can help relieve severe and chronic pain.

“I saw a lot of patients who really, really, really had their pain improved by these drugs, of which OxyContin was only one,” he says.

He also argues some people also abuse pot.

Emblem is one of the newest entries into Canada’s burgeoning pot marketplace. It received its license to grow and sell medical marijuana from Ottawa last year, joining 35 other competitors in an increasingly crowded marketplace.

Investors, which include Mr Stewart, believe it can eventually generate CA$100m ($74m; £60m) in revenue a year.

Ottawa brought in a new regime for medical cannabis – legalised in Canada in 2001 – in 2014, forcing patients to buy their medication through large-scale licensed growers that would ship them dried marijuana. Those new rules helped launch a commercial industry that’s flourishing in the country.

Cultivators like Aphria, Mettrum Health, and Canopy Growth, currently Canada’s largest producer, have become stock market darlings.

In October, Shoppers Drug Mart, one of Canada’s major pharmacy chains, applied to distribute medical marijuana to the current cannabis patients, a number that is growing.

Right now, licensed producers can only ship the product to patients, which Mr Stewart calls “cumbersome”. Patients can also grow limited amounts.

The federal Liberals also plan to introduce a bill this spring to legalise recreational marijuana across the country, which has further fuelled investment in the cannabis sector.

My Marijuana News

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright 2016 www.mymarijuananews.com